Ibogaine: the research, the cardiac risks and the legal picture
Ibogaine research for founders: the Stanford veterans study, QT prolongation and cardiac death risks, Schedule I status and Texas's $50 million trial push.
Psilocybin, ketamine, MDMA, ayahuasca, ibogaine, 5-MeO-DMT, breathwork and integration: what the research shows, the real risks, and how meditation helps make sense of it all.
Ibogaine research for founders: the Stanford veterans study, QT prolongation and cardiac death risks, Schedule I status and Texas's $50 million trial push.
Psilocybin clinical trials show fast, real drops in depression scores, with sharp limits. What the studies found, the risks, and the legal status in 2026.
Psychedelic integration is the work of making sense of an altered-state experience afterward. What the research shows, the legal picture, and the risks.
Meditation for consciousness exploration: what it is, how it differs from stress relief, and a grounded practice for investigating your own mind with rigor.